Blog wide

Viewpoint: Drug developers are abandoning current Alzheimer’s patients. Why is no one complaining?

Although the latest analysis of experimental Alzheimer’s drugs finds that literally zero are being tested in late-stage clinical trials to treat moderate ...
CROP rectangle large

The human cost of the anti-GMO movement: Why one scientist is quitting GE crop research

Constantly confronting people who think my research will harm them is profoundly distressing ...

Suffering for the love of birds: A scientist’s battle to save birds — and now her career

PETA begins to harass and intimidate a rising researcher in the field of animal behavior, scientist Kevin Folta urges the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists